Decitabine. MGI Pharma Inc/SuperGen Inc.
Decitabine is a DNA methyltransferase inhibitor under development by SuperGen Inc and MGI Pharma Inc for the potential treatment of a range of hematological malignancies, including myelodysplastic syndrome, solid tumors and sickle cell disease.